Nobis P, Jaenisch R
Proc Natl Acad Sci U S A. 1980 Jun;77(6):3677-81. doi: 10.1073/pnas.77.6.3677.
BALB/Mo mice carrying the Moloney murine leukemia virus (M-MuLV) as an endogenous virus become viremic soon after birth and develop leukemia at a later age. M-MuLV-specific gene expression and an increase of virus-specific DNA copies in lymphatic target organs are characteristics of the preleukemic phase. Passive immunotherapy of new born BALB/Mo mice with anti-gp70 glycoprotein or anti-M-MuLV serum prevented viremia and delayed significantly the subsequent development of leukemia. Molecular hybridization experiments showed that both virus-specific genome transcription and virus-specific DNA amplification could be completely suppressed by antiserum treatment. Thus virus-specific RNA concentrations in target organs of immunized BALB/Mo mice of 6 months or older were as low as in normal BALB/c mice. This is an age at which untreated BALB/Mo mice have already developed malignant lymphoma. Our experiments demonstrate that treatment with antiserum interferes with the early events of virus expression and thus prevents the subsequent steps leading to leukemia.
携带莫洛尼鼠白血病病毒(M-MuLV)作为内源性病毒的BALB/Mo小鼠在出生后不久就会出现病毒血症,并在后期发展为白血病。M-MuLV特异性基因表达以及淋巴靶器官中病毒特异性DNA拷贝数的增加是白血病前期的特征。用抗gp70糖蛋白或抗M-MuLV血清对新生BALB/Mo小鼠进行被动免疫治疗可预防病毒血症,并显著延迟随后白血病的发展。分子杂交实验表明,抗血清治疗可完全抑制病毒特异性基因组转录和病毒特异性DNA扩增。因此,6个月及以上免疫的BALB/Mo小鼠靶器官中的病毒特异性RNA浓度与正常BALB/c小鼠一样低。在这个年龄,未经治疗的BALB/Mo小鼠已经发展为恶性淋巴瘤。我们的实验表明,抗血清治疗会干扰病毒表达的早期事件,从而阻止导致白血病的后续步骤。